Medical News

RSS

Cellectis bioresearch establishes US subsidiary

Cellectis bioresearch, a specialist in genome customization and subsidiary of Cellectis, today announced that it has established a US subsidiary, Cellectis bioresearch Inc. Located at the Cambridge Innovation Center in Cambridge, Massachusetts, Cellectis bioresearch Inc. will be responsible for the US-wide promotion of Cellectis bioresearch products and services.

13 Oct 2010

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.

From Baxter International Inc. 13 Oct 2010

Ocular Therapeutix completes Proof of Principle clinical study with moxifloxacin punctum plug

Ocular Therapeutix, Inc. announced today the completion of a successful Proof of Principle clinical study with their novel sustained drug delivery moxifloxacin punctum plug.

13 Oct 2010

Experts highlight health issues in growing megacities

Experts at the World Health Summit highlighted health concerns related to the growth of megacities, "roughly defined as cities with a population of more than 10 million," Agence France-Presse reports.

13 Oct 2010

Sirius collaborates with Golden Helix to advance diagnostic pipeline

Sirius Genomics, a developer of companion diagnostics, and Golden Helix, a global leader in genetic analysis solutions, announced today a collaboration under which Golden Helix will apply its expertise and technologies in SNP and copy number variant analysis and predictive modeling to advance development of Sirius' diagnostic pipeline.

13 Oct 2010

Stem cell-enriched autologous fat treatment safe for breast reconstruction after cancer surgery

Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery. Till now though, it was unclear whether this might reactivate the cancer again. However, University of Pittsburgh researchers led by Prof. Albert Donnenberg have now demonstrated that stem cell-enriched autologous fat is safe even in the presence of inactive tumor cells.

13 Oct 2010

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).

13 Oct 2010

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Kennedy Krieger Institute announced today the launch of a first‐of‐its‐kind, phase II clinical trial to investigate a treatment for heart disease in individuals with Duchenne muscular dystrophy (DMD).

13 Oct 2010

Urgent Care Association of America certifies eighteen more facilities

Eighteen more facilities have just received the Certified Urgent Care Center designation awarded by the Urgent Care Association of America. The Certified Urgent Care program helps the public identify urgent care centers and promotes and advances the urgent care industry.

13 Oct 2010

Global Hunger Index shows importance of addressing childhood malnutrition

The Global Hunger Index released Monday finds that many developing countries primarily in South Asia and Latin America have made significant progress in reducing hunger.

13 Oct 2010

New cancer initiative may promote rapid drug development

Greenville Hospital System University Medical Center (GHS) unveiled details of its new Institute for Translational Oncology Research, a visionary cancer initiative that will help pave the way for new breakthroughs in rapid drug development, diagnostic discovery and advanced cancer care. ITOR is part of the GHS Cancer Center, a recognized regional multi-disciplinary center.

13 Oct 2010

NCI rates Abramson Cancer Center as 'exceptional'

The University of Pennsylvania's Abramson Cancer Center has been rated as "exceptional" by the National Cancer Institute (NCI) during a competitive research funding review by the government agency.

13 Oct 2010

New evidence supports possible link between XMRV and prostate cancer

Xenotropic murine leukemia virus-related virus (XMRV) has been the subject of many studies since its discovery in 2006, but conflicting reports have created an unclear picture of XMRV's role in human disease. In three recent studies published in the November 15 issue of The Journal of Infectious Diseases, now available online, the evidence supports a possible link between XMRV and prostate cancer but not other links involving chronic fatigue syndrome, HIV infection, or hepatitis C virus (HCV) infection.

13 Oct 2010

USAID awards $15 million grant to Tufts University for CRSP program

Eileen T. Kennedy, DSc, Dean of the Friedman School of Nutrition Science and Policy at Tufts University announced today that the school has been awarded two grants totaling $15 million by the United States Agency for International Development (USAID). The USAID "Leader with Associates (LWA) Award" was granted to the school to serve as the Management Entity for a new Nutrition Collaborative Research Support Program (CRSP) in Africa and Asia. This is the first CRSP to be awarded by USAID in nearly 25 years.

13 Oct 2010

World Economic Forum index ranks countries by gender disparities

An index issued Tuesday by the World Economic Forum (WEF) ranked 134 countries according to how much they had reduced gender disparities over the past year in the areas of economic participation, education, political empowerment and health, the New York Times reports.

13 Oct 2010

SAMHSA awards State Incentive Grants for substance abuse prevention

The Substance Abuse and Mental Health Services Administration (SAMHSA) announced it is awarding up to $53.4 million in new State Incentive Grants for up to five years. These grants are used by states or tribes to implement a strategic approach in communities across the state for substance abuse prevention.

13 Oct 2010

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Cardio-metabolic risk factors such as high blood sugar and insulin, and low high density lipoprotein cholesterol that are present before pregnancy, predict whether a woman will develop diabetes during a future pregnancy, according to a Kaiser Permanente study in the current issue of the American Journal of Epidemiology.

13 Oct 2010

Some states snub health reform; in others, election will decide fate of law's implementation

Politico reports that races at the state level could affect the health law more than congressional races. Governors who oppose the legislation can refuse to set up pieces of the law, such as the state-based insurance exchanges where most Americans will purchase coverage beginning in 2014.

13 Oct 2010

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

A pregnant woman's immune response to viral infections may induce subtle neurological changes in the unborn child that can lead to an increased risk for neurodevelopmental disorders including schizophrenia and autism. Research published in the online journal mBio- provides new insights into how this may happen and suggests potential strategies for reducing this risk.

13 Oct 2010

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Donor kidneys can be successfully transplanted even if there is strong tissue incompatibility between donor and recipient. An interdisciplinary working group headed by Dr. Christian Morath, senior consultant at the Department of Nephrology at Heidelberg University Hospital (Medical Director: Professor Dr. Martin Zeier) and Professor Dr. Caner S-sal, head of antibody laboratory in the Department of Transplantation Immunology, showed in a study of 34 sensitized high-risk patients that the success rate in these patients was not different from the success rate of patients with a low immunological risk.

13 Oct 2010

Medical News

Cellectis bioresearch establishes US subsidiary

BioRx receives limited distribution rights from Baxter for AATD drug GLASSIA

Ocular Therapeutix completes Proof of Principle clinical study with moxifloxacin punctum plug

Experts highlight health issues in growing megacities

Sirius collaborates with Golden Helix to advance diagnostic pipeline

Stem cell-enriched autologous fat treatment safe for breast reconstruction after cancer surgery

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Kennedy Krieger Institute launches phase II clinical trial to investigate Revatio for DMD treatment

Urgent Care Association of America certifies eighteen more facilities

Global Hunger Index shows importance of addressing childhood malnutrition

New cancer initiative may promote rapid drug development

NCI rates Abramson Cancer Center as 'exceptional'

New evidence supports possible link between XMRV and prostate cancer

USAID awards $15 million grant to Tufts University for CRSP program

World Economic Forum index ranks countries by gender disparities

SAMHSA awards State Incentive Grants for substance abuse prevention

Metabolic screening before conception predicts development of diabetes in subsequent pregnancy

Some states snub health reform; in others, election will decide fate of law's implementation

Infection during pregnancy linked to increased risk for neurodevelopmental disorders in fetus

Researchers develop new therapy to overcome tissue incompatibility in kidney transplantation

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News